Skip to main content

Shanghai Shengya Aesthetic Medical Hospital’s Dr. Wang Jingang Gains Global Recognition for Innovative Facelift Technique

-- Innovation & Technology

Since its founding, Shanghai Shengya Aesthetic Medical Hospital has prioritized technological innovation, supporting clinical research and surgical development. Under this framework, Dr. Wang Jingang developed the “Three-Plane High-SMAS Facelift”, integrating multi-layer lifting with precision nerve preservation. Clinical outcomes show over 95% patient satisfaction, 30% faster recovery, and long-lasting results up to 8–10 years, attracting patients from around the globe.

Academic Achievements

Dr. Wang’s academic achievements include:
- 2023: “Clinical Application of High-SMAS Combined with Subperiosteal Brow Lift in Facial Rejuvenation”, published in the Chinese Journal of Aesthetic Medicine, awarded Outstanding Paper of the Year.
- 2024: “Short-Incision Temporal High-SMAS Facelift Technique”, published in Aesthetic Plastic Surgery, with data from 200 international patients.

The hospital actively participates in top conferences, and Dr. Wang’s keynote presentations have elevated the institution’s academic and global influence.

International Collaboration

Guided by the philosophy “Rooted in China, Engaged with the World”, the hospital promotes global collaboration:
- 2024: Dr. Wang conducted live surgeries and workshops in Uzbekistan, providing structured “theory + practice” training.
- 2025: Hosted 12 visiting specialists from Russia, Kazakhstan, and Iran for a one-month Clinical Observation Fellowship Program, reinforcing international knowledge exchange.

Future Outlook

Shanghai Shengya Aesthetic Medical Hospital continues to lead Chinese aesthetic medicine from consumer-focused innovation to global medical knowledge contribution, setting benchmarks in precision-based, minimally invasive facial rejuvenation.

Contact Info:
Name: Shengya PR Department
Email: Send Email
Organization: Shanghai Shengya Medical Aesthetics Hospital
Website: https://www.anyqu.com/

Release ID: 89173901

In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.82
+1.57 (0.68%)
AAPL  269.27
+0.27 (0.10%)
AMD  261.31
+3.30 (1.28%)
BAC  52.78
-0.09 (-0.16%)
GOOG  272.60
+4.17 (1.55%)
META  748.50
-2.94 (-0.39%)
MSFT  538.84
-3.23 (-0.60%)
NVDA  207.09
+6.06 (3.01%)
ORCL  277.06
-3.77 (-1.34%)
TSLA  461.37
+0.82 (0.18%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.